Day One Biopharmaceuticals, Inc.
DAWN
Amendment
Ownership
0.00%
Total Shares
0
Issuer CIK
1845337
Event Date
Apr 22, 2026
Accepted
Apr 27, 2026, 05:55 PM
SEC EDGARView Original Filing
Reporting Persons (4)
Joint Filing
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| AI Day1 LLC | Other | 0.00% | 0 | 0 | 0 |
| Access Industries Holdings LLC | Other | 0.00% | 0 | 0 | 0 |
| Access Industries Management, LLC | Other | 0.00% | 0 | 0 | 0 |
| Len Blavatnik | Individual | 0.00% | 0 | 0 | 0 |
Disclosure Items (3)
Security Title
Common Stock, par value $0.0001 per share
Issuer Name
Day One Biopharmaceuticals, Inc.
Issuer Address
1800 Sierra Point Parkway, Brisbane, CA, 94005
Percentage of Class
Item 5 of the Schedule 13D is hereby amended and restated as follows: As a result of the Tender Offer, the Reporting Persons no longer have any beneficial ownership in the Common Stock.
Transactions
The information set forth in Item 4 of this Schedule 13D is incorporated by reference herein.
Shareholders
Not applicable.
Date of 5% Ownership
The Reporting Persons ceased to be beneficial owners of more than five percent of the Issuer's Common Stock on April 23, 2026.